This grant offers funding for the continuation of the Drug-induced Liver Injury Network (DILIN), a critical initiative aimed at addressing one of the most challenging forms of liver disease. The network will consist of up to five clinical center sites and a single data coordinating center, focusing on advancing research into drug-induced liver injury (DILI). DILI presents significant diagnostic and management hurdles, with numerous pharmaceutical drugs, nutritional supplements, and herbal medications implicated in causing liver damage. Its clinical manifestations are highly variable, often mimicking other liver conditions. This funding opportunity encourages applications from qualified investigators at clinical centers to contribute to ongoing efforts in understanding and managing this complex disease.
Opportunity ID: 212254
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-13-003 |
| Funding Opportunity Title: | Continuation of the Clinical Centers for the Drug Induced Liver Injury Network [DILIN] (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 20, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Feb 27, 2013 |
| Current Closing Date for Applications: | Feb 27, 2013 |
| Archive Date: | Mar 30, 2013 |
| Estimated Total Program Funding: | $2,330,000 |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts County governments Small businesses Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Public and State controlled institutions of higher education State governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from qualified investigators from clinical centers for the continuation of the Drug-induced Liver Injury Network (DILIN). This network will consist of up to 5 clinical center sites and a single data coordinating center.
Drug-induced liver injury is one of the more challenging forms of liver disease; both in diagnosis and management. Several hundred drugs, nutritional supplements and herbal medications have been implicated in causing liver injury. Their clinical presentation can be highly variable and mimic almost any form of liver disease. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-003.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.847 | ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00157110 | Jan 27, 2013 | Feb 27, 2013 | View |
Package 1
Mandatory forms
212254 RR_SF424_1_2-1.2.pdf
212254 PerformanceSite_1_4-1.4.pdf
212254 RR_OtherProjectInfo_1_3-1.3.pdf
212254 RR_KeyPersonExpanded_1_2-1.2.pdf
212254 PHS398_CoverPageSupplement_1_4-1.4.pdf
212254 PHS398_ResearchPlan_1_3-1.3.pdf
212254 PHS398_Checklist_1_3-1.3.pdf
Optional forms
212254 RR_SubawardBudget30-1.2.pdf
212254 PHS398_ModularBudget_1_2-1.2.pdf
212254 RR_Budget-1.1.pdf
212254 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
